• 1
    Amy DK, Thomas BN. Loiasis and mansonella infections. In: Guerrant RL, Walker DH, Weller PF, eds. Pat 99: tropical infectious diseases; principles, pathogens, & practice. Vol 2. 2nd Ed. Philadelphia: Elsevier Churchill Livingstone, 2006:11631175.
  • 2
    Madell SH, Spingarn GL. Unusual thoracic manifestations in filariasis due to Loa loa; results of treatment with hetrazan and naphuride sodium. Am J Med 1953; 15:272280.
  • 3
    Klion AD, Eisenstein EM, Smimiotopoulos TT, et al. Pulmonary involvement in loiasis. Am Rev Respir Dis 1992; 145(4 Pt 1):961963.
  • 4
    Hautekeete ML, Pailoux G, Marcellin P, et al. Presence of Loa loa microfilariae in ascitic fluid. J Infect Dis 1989; 160:559560.
  • 5
    Anakwue RC, Onwubere BJ, Anisiuba BC, et al. Congestive heart failure in subjects with thyrotoxicosis in a black community. Vasc Health Risk Manag 2010; 6:473477.
  • 6
    Andy JJ, Bishara FF, Soyinka OO, Odesanmi WO. Loiasis as a possible trigger of African endomyocardial fibrosis: a case report from Nigeria. Acta Trop 1981; 38:179186.
  • 7
    Andy JJ, Ogunowo PO, Akpan NA, et al. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 1998; 69:127140.